Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equinacea Arkopharma for symptom control in COVID-19
2021-000850-24Phase 4Active
- Sponsor
- Jesús RodrÃguez Requena
- Start
- Sep 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of echinacea extract in coronavirus disease 2019 (COVID-19), sponsored by Jesús RodrÃguez Requena. Primary endpoint: Duration of fever. Started Sep 2021; status: active.
02
Drugs
echinacea extract
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-000850-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000850-24.